Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com

StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report released on Sunday morning. The firm issued a sell rating on the basic materials company’s stock.

Separately, HC Wainwright restated a “buy” rating and issued a $6.00 price target on shares of Arcadia Biosciences in a research report on Wednesday, August 21st.

Arcadia Biosciences Price Performance

RKDA stock opened at $2.79 on Friday. The stock has a market capitalization of $3.79 million, a price-to-earnings ratio of -0.65 and a beta of 1.27. The business’s fifty day moving average price is $3.32 and its two-hundred day moving average price is $3.07. Arcadia Biosciences has a fifty-two week low of $1.85 and a fifty-two week high of $5.34.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.